A-rated quality moves to fair value, then deeper research comes next.
Medronic is treated as a high-quality, A-rated medical name that has moved into fair value and then warrants extra due diligence.
The commentary says Medronic is coming into fair value after trading more optimally, and the next step is checking other research sources such as Morningstar. The emphasis is on due diligence once valuation reaches the acceptable range.